Successful Treatment of PD-1 Inhibitor-induced Psoriasis with Infliximab
Standard
Successful Treatment of PD-1 Inhibitor-induced Psoriasis with Infliximab. / Hansen, I; Heidrich, I; Abeck, F; Kött, J; Booken, N; Gebhardt, C; Schneider, S W.
in: J EUR ACAD DERMATOL, Jahrgang 37, Nr. 5, 05.2023, S. e621-e623.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Letter › Forschung
Harvard
Hansen, I, Heidrich, I, Abeck, F, Kött, J, Booken, N, Gebhardt, C & Schneider, SW 2023, 'Successful Treatment of PD-1 Inhibitor-induced Psoriasis with Infliximab', J EUR ACAD DERMATOL, Jg. 37, Nr. 5, S. e621-e623. https://doi.org/10.1111/jdv.18780
APA
Hansen, I., Heidrich, I., Abeck, F., Kött, J., Booken, N., Gebhardt, C., & Schneider, S. W. (2023). Successful Treatment of PD-1 Inhibitor-induced Psoriasis with Infliximab. J EUR ACAD DERMATOL, 37(5), e621-e623. https://doi.org/10.1111/jdv.18780
Vancouver
Hansen I, Heidrich I, Abeck F, Kött J, Booken N, Gebhardt C et al. Successful Treatment of PD-1 Inhibitor-induced Psoriasis with Infliximab. J EUR ACAD DERMATOL. 2023 Mai;37(5):e621-e623. https://doi.org/10.1111/jdv.18780
Bibtex
@article{5787c048f3be4a52b8a37bbea27a2dee,
title = "Successful Treatment of PD-1 Inhibitor-induced Psoriasis with Infliximab",
author = "I Hansen and I Heidrich and F Abeck and J K{\"o}tt and N Booken and C Gebhardt and Schneider, {S W}",
year = "2023",
month = may,
doi = "10.1111/jdv.18780",
language = "English",
volume = "37",
pages = "e621--e623",
journal = "J EUR ACAD DERMATOL",
issn = "0926-9959",
publisher = "Wiley-Blackwell",
number = "5",
}
RIS
TY - JOUR
T1 - Successful Treatment of PD-1 Inhibitor-induced Psoriasis with Infliximab
AU - Hansen, I
AU - Heidrich, I
AU - Abeck, F
AU - Kött, J
AU - Booken, N
AU - Gebhardt, C
AU - Schneider, S W
PY - 2023/5
Y1 - 2023/5
U2 - 10.1111/jdv.18780
DO - 10.1111/jdv.18780
M3 - Letter
C2 - 36424911
VL - 37
SP - e621-e623
JO - J EUR ACAD DERMATOL
JF - J EUR ACAD DERMATOL
SN - 0926-9959
IS - 5
ER -
